Mountain Valley Orthopedics in East Stroudsburg, PA, is transforming orthopedic care with Prescribe FIT, a program focused on lifestyle management and personalized health coaching to achieve ...

Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced that the FDA has ...

The Human Animal Bond Research Institute (HABRI) is proud to announce an insightful panel discussion, "The Last Goodbye: The ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva ...

Pharma stocks have underperformed the market in the fourth quarter with the Stoxx Europe 600 Health Care index--which is heavily dominated by Europe's six largest pharma companies--down 9.4% against a ...

Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) is expected to be announcing its earnings results before the market opens on Wednesday, January 29th. Analysts expect the company to ...

NICE Systems Ltd. (Nasdaq: NICE; TASE: NICE) rose 6.16% for the biggest rise on the Tel Aviv 35 Index today. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA rose 1.75%, Ormat Technologies ...

Three players in the biosimilar space have already sparked hope for the new year, with each having big business or regulatory ...

Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) had its price target raised by UBS Group from $28.00 to $30.00 in a research note published on Thursday,Benzinga reports. UBS Group currently ...

Coral Gables, FL-based Catalyst Pharmaceuticals , Inc. (NASDAQ:CPRX), a $2.69 billion market cap biopharmaceutical company that has delivered an impressive 54% return to shareholders over the past ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.